Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

Infermedica is a Polish company founded in 2012 that builds symptom assessment and triage technology for health systems and insurers. Its probabilistic reasoning engine, curated by physicians, guides patients to the right level of care and integrates into call centres, apps and patient portals. The technology is licensed in dozens of countries and supports many languages.

News

News CB Herald 3 months ago
An AI health assistant Australians can trust, with a nurse always one step away
When an Australian opens ChatGPT late at night to ask about a child's fever, a sudden pain, or a mole that has changed, they are usually on their own with their smartphone. Healthdirect Australia is setting out to change that. Today Healthdirect announced
Read more
Report
Press release EIN Presswire 3 months ago
Healthdirect Australia, Infermedica and Partners Collaborate on ChatGPT Health Service Pilot
Healthdirect Australia is collaborating with Infermedica, Skin Analytics, AWS and DEPT to bring trusted AI-powered health guidance into ChatGPT
Read more
Report
News Health Services Daily 3 months ago
Healthdirect testing ChatGPT integration to connect Aussies directly to nurses
The national health information provider is partnering with OpenAI, Infermedica and Skin Analytics on an AI-powered proof of concept, with consumer testing to begin soon.
Read more
Report
Press release EIN Presswire 11 months ago
Infermedica Joins Outshift by Cisco, Webex, and AI Innovators to Launch Next-Generation Healthcare Automation Prototype
Prototype demonstrates seamless collaboration between AI agents to streamline symptom triage, insurance checks, and doctor appointment booking.
Read more
Report
Press release EIN Presswire 12 months ago
Infermedica Achieves MDR Class IIb Certification for its AI-Powered Medical Guidance Platform
Infermedica earns EU MDR Class IIb certification, validating its AI platform's safety, clinical rigor, and regulatory compliance.
Read more
Report
Pro access
Upgrade to see all 40 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.